Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Equity Average (2016 - 2025)

Historic Equity Average for Bristol Myers Squibb (BMYMP) over the last 16 years, with Q4 2025 value amounting to $18.6 billion.

  • Bristol Myers Squibb's Equity Average rose 1047.4% to $18.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.6 billion, marking a year-over-year increase of 1047.4%. This contributed to the annual value of $17.4 billion for FY2025, which is 4378.46% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Equity Average is $18.6 billion, which was up 1047.4% from $18.0 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Equity Average peaked at $41.0 billion during Q1 2021, and registered a low of $16.8 billion during Q4 2024.
  • For the 5-year period, Bristol Myers Squibb's Equity Average averaged around $29.5 billion, with its median value being $32.1 billion (2022).
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 5506.38% in 2024, then soared by 1047.4% in 2025.
  • Bristol Myers Squibb's Equity Average (Quarter) stood at $40.8 billion in 2021, then dropped by 4.59% to $38.9 billion in 2022, then fell by 4.05% to $37.4 billion in 2023, then plummeted by 55.06% to $16.8 billion in 2024, then increased by 10.47% to $18.6 billion in 2025.
  • Its Equity Average was $18.6 billion in Q4 2025, compared to $18.0 billion in Q3 2025 and $17.5 billion in Q2 2025.